Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0021051 (
immunodeficiency
)
71,517
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Monocytes in a familial monocyte disorder, a recently recognized primary
immunodeficiency syndrome
, with impaired phagocytic functions were studied for their ability to produce interleukin 1 (IL-1) as well as the surface property. Monocytes from two children (siblings) with the disorder possessed CD11b, CD13, CD14, CD33, Ia and LFA-1/Mac-1/p150,95 beta subunit antigens as determined by flow cytometry. Electron microscopic cytochemistry showed that the monocytes had surface glycoproteins reactive with four representative lectins. The IL-1 production by monocytes was assayed in the two patients and compared with that in six children with primary
immunodeficiency
syndromes and some monocyte abnormalities; three had congenital neutropenia, two had hyper-IgE syndrome, and one had defective monocyte chemotaxis. Monocyte culture supernatants were prepared with stimulation by
lipopolysaccharide
or silica, and their IL-1 activity was measured by the mouse thymocyte-proliferation assay. The patients' monocytes were defective in IL-1 production: the values were less than 1.0% of the control monocyte values (n = 12) and were in contrast with those of congenital neutropenia monocytes of 186.2% to 204.3%. These results demonstrate a familial monocyte disorder which is characteristic among the
immunodeficiency
syndromes with regard to the defective IL-1 production and the impaired phagocytic functions.
...
PMID:Defective interleukin-1 production in a familial monocyte disorder with a combined abnormality of mobility and phagocytosis-killing. 326 74
Mice were given single injections of sheep erythrocytes (SE) or polyvinylpyrrolidone (PVP) at various times after sublethal, whole-body irradiation (550 rad 60CO) and direct, antigen-specific, plaque-forming cell (PFC) responses were quantified. Irradiated mice did not respond to SE or PVP when immunized 15 d postirradiation (PI); by day 30 PI, the responses by irradiated mice were 40-126% of normal to SE and 3-38% of normal to PVP. The impaired recovery after irradiation of immune responses to PVP was not due to altered antigen dose requirements or altered time of peak PFC response and occurred after irradiation of mice by doses as low as 200 rad. Both athymic and euthymic mice had impaired responses to PVP after whole-body irradiation. The impaired response of irradiated mice to PVP was repaired by adoptive transfer of normal bone marrow, fetal liver, or spleen cells and also by spleen cell preparations enriched in Ig+ cells but not by spleen cell preparations enriched in Thy.1+ or Ig- cells. With the aid of additional antigens it was observed that by day 30 PI, mice had recovered ability to respond to the T-cell-dependent antigen SE and the T-cell-independent type-1 antigens 2,4,6-trinitrophenyl-Brucella abortus and butanol-extracted bacterial
lipopolysaccharide
, but at that time they gave impaired responses to the T-cell-independent type-2 antigens PVP, type III pneumococcal polysaccharide, and phenol-extracted bacterial
lipopolysaccharide
; they had an immune response pattern similar to that of CBA/N mice having an X-linked
immunodeficiency
.
...
PMID:Differential recovery of antibody production potential after sublethal, whole-body irradiation of mice. 352 64
Nine patients with gynecologic malignancies (six cervix, two endometrium and one ovary) were injected with acid-treated Salmonella minnesota R595 (Re). Patients received a total of four injections (at increasing doses from 0.5 to 3 micrograms) every 2 weeks. All patients, before treatment, had a severe impairment of their immune system either of cell-mediated immunity (leukocyte inhibiting factor activity) or non-specific immunity (polymorphonuclear cell and/or monocyte-mediated phagocytosis and killing). In contrast, the same patients displayed a normal Natural Killer cell frequency in their peripheral blood as evaluated in an agarose-single cell cytotoxic assay. At the end of the immunotherapeutic regimen, all the above immune functions significantly augmented likely via an immunomodulating effect exerted by the lipid A portion of Salmonella minnesota Re which represents the
lipopolysaccharide
molecule in these bacteria. This suggests a potential role for lipid A in the treatment of cancer-related
immunodeficiency
.
...
PMID:Relationship between immune system and gram-negative bacteria. Acid-treated Salmonella minnesota R595 (Re) enhances immune responsiveness in patients with gynecologic malignancies. 380 33
The relative capacities of two classes of immunomodulator to augment the deficient immunity of senescent mice were evaluated. Bacterial
lipopolysaccharide
(
LPS
) was used as the prototype for modulators that depend on normal membrane function for signal transduction, and 8-mercaptoguanosine (8MGuo) represents a class of immunomodulator that transverses the cell membrane and induces its effects from an intracellular location. The current studies demonstrate that 8MGuo induces polyclonal immunoglobulin production in cultures from both young and senescent mice, whereas
LPS
can induce such activity only in cell cultures from young adult mice. Furthermore,
LPS
was unable to enhance the magnitude of antigen-specific responses in aged mice, in contrast to the marked adjuvant effects of 8MGuo. 8MGuo, but not
LPS
, provided an effective T cell-like signal that induced responsiveness to a T-dependent antigen in B cells from senescent mice. These B cells thus were able to transduce antigen-specific (first) but not nonspecific (second) signals, provided by agents such as
LPS
, across the cell membrane. Together, these observations suggest that the C8-derivatized guanine ribonucleosides substantially improve the
immunodeficiency
of aging by short-circuiting a B cell defect and providing a perceived second signal to lymphocytes from senescent animals.
...
PMID:Restoration of humoral immunity in vitro in immunodeficient aging mice by C8-derivatized guanine ribonucleosides. 387 3
The restoration of immune functions was followed in dogs for 101 days after fractionated total body irradiation and autologous transfusion of peripheral blood leukocytes (PBL) or bone marrow (BM) cells. Median numbers of 0.9 X 10(5) granulocyte-macrophage progenitor cells per kilogram of body weight were transferred in either group of recipients. The following parameters recovered more rapidly in PBL recipients as opposed to BM recipients: total blood lymphocyte, T- and B-cell counts, serum levels of immunoglobulins IgM and IgA, in vitro blastogenic responses after stimulation with concanavalin A and pokeweed mitogen, and in vitro plasma cell formation after polyclonal B-cell activation with pokeweed mitogen with or without
lipopolysaccharide
. No major differences were noted for the restoration of serum IgG levels. Circulating lymphocyte and T-cell numbers remained subnormal for more than three months in both groups, whereas B-cell numbers and serum levels of IgA continued to be depressed in BM recipients only. Thus, autologous PBL restored immune functions more rapidly than did BM. Transplantation of PBL, alone or in addition to autologous BM, might also shorten the period of
immunodeficiency
after cytoreduction in a variety of malignancies in man.
...
PMID:Recovery of immune functions in dogs after total body irradiation and transplantation of autologous blood or bone marrow cells. 389 1
Culture fluid (CF) from LA cells (LA-CF) strongly stimulated the proliferation of normal A/J mouse spleen cells in vitro. This activity was nondialyzable, labile to 56 degrees C for 20 min., sedimentable, H-2 and species unrestricted, and was found to be mycoplasma-derived. LA-CF was active for B cells because in vitro treatment of A/J spleen cells with anti mouse Ig antiserum and complement eliminated their responsiveness to LA-CF. LA-CF stimulated the resting, small spleen cells of the nude mouse as strongly as
lipopolysaccharide
(
LPS
) did. Spleen cells of the X chromosome-linked
immunodeficiency
(Xid) mouse were stimulated by
LPS
to a half of the control mice, and by LA-CF to a quarter of the control.
LPS
-low responder (C3H/HeJ) spleen cells were also stimulated by LA-CF. The mycoplasma(s)-derived B cell mitogen in the LA-CF was different from
LPS
.
...
PMID:Comparison of mycoplasma(s)-derived B cell mitogenic activity with lipopolysaccharide. 390 4
CBA/N mice, which possess an X-linked
immunodeficiency
(xid), produce a convincing antibody response to
lipopolysaccharide
derived from Escherichia coli 0113 (LPS 0113), a thymus-independent antigen. The antibody response produced was shown to be specific for the O-polysaccharide moiety of LPS 0113, rather than lipid A or lipid-A-associated protein. The relevance of this finding to the nature of the genetic defect of xid-mice is discussed.
...
PMID:Antibody response of immunodeficient (xid) CBA/N mice to Escherichia coli 0113 lipopolysaccharide, a thymus-independent antigen. 618 86
The capacity of heat-killed meningococci and the polysaccharide-protein-
lipopolysaccharide
fraction ( PPLF ) isolated from the microbial cell wall for changing nonspecific immunological reactivity was studied. In this investigation CBA mice with high response and C57BL/6 mice with low response to sheep red blood cells (SRBC) were used. Heat-killed N. meningitidis, serogroup A, and PPLF , serogroups A and B, were found to enhance and suppress humoral response to the heterologous antigen. The effect of modulation depended on the dose of the antigen, the serogroup of meningococci, the scheme of the experiment and the strain of mice. The immune response of the vaccinated animals to the heterologous antigen was characterized by the following stages: the state of the adjuvant effect was replaced by the state of temporary
immunodeficiency
and then by enhanced response to SRBC.
...
PMID:[Effect of Neisseria meningitidis on the humoral response of various strains of mice immunized with ram erythrocytes]. 642 80
Intravenous transfer of BALB/c spleen cells (1-10 X 10(6] immunized against semi-allogeneic hybrid cells bearing H-2k antigens into BALB/c mice resulted in splenomegaly (2- to 6-fold). As few as 2 X 10(4) spleen cells could transfer splenomegaly. A significant spleen enlargement was seen from 2 weeks after cell transfer and reached the peak level at 3 weeks. Those mice with splenomegaly displayed markedly reduced levels of proliferative responses to concanavalin A and
lipopolysaccharide
. However, the levels of the major Ig classes (i.e., IgG, IgM, and IgA) in the immunodeficient mice were significantly elevated. Such induction of
immunodeficiency
in mice may help further to understand the acquired immunodeficiency syndrome of humans.
...
PMID:Induction of immunodeficiency in mice by injection with syngeneic splenocytes immune to semi-allogeneic hybrid cells. 647 14
The relationship between colony formation (cloning) of B cells and their activation in murine autoimmunity was investigated in MRL-lpr/lpr and MRL.xid mice. Cells from MRL-lpr/lpr mice showed similar requirements for in vitro growth as normal CBA/J and BALB/c cells, with maximal colony formation in the presence of the supporting factors
lipopolysaccharide
and sheep red blood cells. The frequency of colony-forming cells from MRL-lpr/lpr spleens or hapten-specific B-cell preparations was slightly greater than the two normal control strains, with this difference significant only for a comparison of BALB/c and MRL-lpr/lpr spleens. In contrast, MRL-lpr/lpr mice bearing the xid gene for B-cell
immunodeficiency
(MRL.xid) had markedly reduced B-cell colony formation. These mice nevertheless expressed anti-DNA antibodies, although at levels reduced from that of MRL-lpr/lpr controls. These results indicate that enhanced in vitro colony formation need not accompany B-cell hyperactivity in murine autoimmune disease and that autoantibody production can occur in mice with impairment in this growth property.
...
PMID:Cloning of B cells from autoimmune MRL-lpr/lpr and MRL.xid mice. 660 79
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>